6 h, 24 h, 48 h. Controls simultaneously received an equivolume of saline (5 ml/kg). Assessments were carried out at 10 min, 30 min, 1 h, 6 h, 24 h and 48 h thereafter. Results: In rats with 48 h-ICV ligation, BPC 157 salutary effect was elicited at any point of 48h-ligation-time. BPC 157 (10 µg,10 ng/kg, both early (i.e., 1 ml bath at 5 min ligationtime) and delayed therapy (intraperitoneally)) counteracts thrombosis and all manifestations of 48 h-ICV ligation (syndrome), i.e., instead progressive DVT, the length and weight of the formed clot considerably less; instead thickened, intima as thick as the nuclei of normal spindle-shaped endothelial cells; instead substantially increased bleeding with an injury and thrombocytopenia, BPC 157-rats bleed less, and have no thrombocytopenia; blood pressure brought to normal values in both ICV and abdominal aorta, vein hypertension and systemic hypotension counteracted, almost normal eye fundus, tachycardia normalized, attenuated ischemia, gross organ congestion greatly prevented or reduced, collaterals and redistribution of otherwise trapped blood volume rapidly presented, and thereby attenuated drinking, leg edema and cyanosis. Conclusions: Pentadecapeptide BPC 157 counteracts DVT and all manifestations of 48h-ICV ligation in rats. 
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